NCT01666925View on ClinicalTrials.gov

Efficacy of Malaria Vaccines in Kenyan Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Malaria
Interventions
BIOLOGICAL

ChAd63 ME-TRAP / MVA ME-TRAP prime-boost immunisation

ChAd63 ME-TRAP: 5 x 10\^10vp MVA ME-TRAP: 2 x 10\^8 pfu

BIOLOGICAL

Rabies vaccine

2 x 2.5IU Verorab

Trial Locations (1)

PO Box 230, 80108

KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast, Kilifi

All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

University of Oxford

OTHER

NCT01666925 - Efficacy of Malaria Vaccines in Kenyan Adults | Biotech Hunter | Biotech Hunter